Uni-Bio Science Group Limited — Board/Management Information 2012

Dec 4, 2012

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [316 x 59] intentionally omitted <==

(incorporated in the Cayman Islands with limited liability)

(stock code: 690)

APPOINTMENT OF EXECUTIVE DIRECTOR, APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS, MEMBERS OF THE AUDIT COMMITTEE AND MEMBERS OF THE REMUNERATION COMMITTEE

The Board announces that with effect from 1 December 2012, Mr. Leung Ka Chun, an independent non-executive director and the chairman of the nomination committee, has been appointed as executive director of the Company.

The Board is pleased to announce that Mr. Ng Pak Kin, Danny and Mr. Leung Wai Chung, Vincent have been appointed as independent non-executive Directors, members of the audit committee and members of the remuneration committee of the Company with effect from 1 December 2012.

The board (“ Board ”) of Directors announces that with effect from 1 December 2012, Mr. Leung Ka Chun (“ Mr. Leung ”), an independent non-executive director and the chairman of the nomination committee of the Company since 25 June 2010, has been appointed as executive director of the Company.

Mr. Leung, aged 35, has over 13 years of working experience in legal profession and commerce especially in the marketing and management field. Mr. Leung holds a Law Diploma from The University of Hong Kong and a China Law Diploma from The Chinese University of Hong Kong. Mr. Leung is currently a senior executive of a law firm. Mr. Leung is also experienced in the bio-chemical and environmental industry. He is a director of

• For identification purpose only

– 1 –

Fitwell Development Limited (“ Fitwell ”), a private limited company incorporated in the British Virgin Islands. Fitwell specializes in recycling of wasted oil, production and marketing of bio-diesel.

Save as disclosed above, Mr. Leung has not previously held any position with the Company or any of its subsidiaries nor has been a director in any other listed company in Hong Kong or overseas in the past three years. Mr. Leung does not have any relationship with the other Directors, the senior management, the substantial shareholders or the controlling shareholders of the Company. As at the date of this announcement, Mr. Leung does not have any interest in the securities of the Company within the meaning of Part XV of the Securities and Future Ordinance (Chapter 571 of the laws of Hong Kong).

Pursuant to the appointment letter between Mr. Leung and the Company dated 1 December 2012, the appointment of Mr. Leung is for a term of two years. He is subject to retirement by rotation and other related provisions as stipulated in the articles of association of the Company. Mr. Leung is entitled to a director’s fee of HK$30,000 per month which is determined by the Board with reference to his duties and responsibilities.

Save as disclosed above, there is no other information in relation to Mr. Leung’s appointment that is required to be disclosed pursuant to any of the requirements of the rule 13.51(2) of the Listing Rules or there is no other matter that needs to be brought to the attention of shareholders of the Company.

The board is also pleased to announce that Mr. Ng Pak Kin, Danny (吳伯乾) (“ Mr. Ng ”) and Mr. Leung Wai Chung, Vincent (梁偉聰) (“ Mr. Vincent Leung ”) have been appointed as the independent non-executive Directors, members of the audit committee and members of the remuneration committee of the Company with effect from 1 December 2012.

Mr. Ng, aged 34, is a practicing Barrister-at-Law, has over 11 years of working experience in the legal profession. Mr. Ng holds a Law Degree (LLB) and a Postgraduate Certificate in Laws (PCLL) from the University of Hong Kong. His legal practice mainly rests on civil litigation including tort, contract and commercial law. He is also familiar with other legal matters in relation to the Securities and Futures Commission.

Mr. Ng has not previously held any position with the Company or any of its subsidiaries nor has been a director in any other listed company in Hong Kong or overseas in the past three years. Mr. Ng does not have any relationship with the other Directors, the senior management, the substantial shareholders or the controlling shareholders of the Company. As at the date of this announcement, Mr. Ng does not have any interest in the securities of the Company within the meaning of Part XV of the Securities and Future Ordinance (Chapter 571 of the laws of Hong Kong).

– 2 –

Pursuant to the appointment letter between Mr. Ng and the Company dated 1 December 2012, the appointment of Mr. Ng is for a term of two years. He is subject to retirement by rotation and other related provisions as stipulated in the articles of association of the Company. Mr. Ng is entitled to a director’s fee of HK$10,000 per month which is determined by the Board with reference to his duties and responsibilities.

Save as disclosed above, there is no other information in relation to Mr. Ng’s appointment that is required to be disclosed pursuant to any of the requirements of the rule 13.51(2) of the Listing Rules or there is no other matter that needs to be brought to the attention of shareholders of the Company.

Mr. Vincent Leung, aged 26, is a Registered Pharmacist (General Pharmaceutical Council, United Kingdom). Mr. Vincent Leung obtained his Master Degree in Pharmacy (MPharm) from University of Nottingham in 2011. He was appointed by several pharmaceutical companies in the United Kingdom as Pharmacy Assistant and Pre-registered Pharmacist from 2006 to 2011.

Mr. Vincent Leung has not previously held any position with the Company or any of its subsidiaries nor has been a director in any other listed company in Hong Kong or overseas in the past three years.

Mr. Vincent Leung does not have any relationship with the other Directors, the senior management, the substantial shareholders or the controlling shareholders of the Company. As at the date of this announcement, Mr. Vincent Leung does not have any interest in the securities of the Company within the meaning of Part XV of the Securities and Future Ordinance (Chapter 571 of the laws of Hong Kong).

Pursuant to the appointment letter between Mr. Vincent Leung and the Company dated 1 December 2012, the appointment of Mr. Vincent Leung is for a term of two years. He is subject to retirement by rotation and other related provisions as stipulated in the articles of association of the Company. Mr. Vincent Leung is entitled to a director’s fee of HK$10,000 per month which is determined by the Board with reference to his duties and responsibilities.

– 3 –

Save as disclosed above, there is no other information in relation to Mr. Vincent Leung’s appointment that is required to be disclosed pursuant to any of the requirements of the rule 13.51(2) of the Listing Rules or there is no other matter that needs to be brought to the attention of shareholders of the Company.

The Board would like to take this opportunity to express its warm welcome to Mr. Ng and Mr. Vincent Leung.

By order of the Board Uni-Bio Science Group Limited TONG Kit Shing Chairman

Hong Kong, 4 December 2012

As at the date of this announcement, the executive directors of the Company are Mr. TONG Kit Shing (Chairman), Mr. LIU Guoyao and Mr. LEUNG Ka Chun; the independent non-executive directors of the Company are Mr. TSAO Hoi Ho, Terry, Mr. LOU Iok Kuong, Mr. NG Pak Kin, Danny and Mr. LEUNG Wai Chung, Vincent.

– 4 –